State and Federal prisons in the United States currently house nearly 1.6 million inmates, the majority of whom have drug problems. Treating drug-involved inmates is a potentially powerful strategy for reducing addiction's impact on public safety and public health. Evaluations of prison treatment programs, which have focused mainly on therapeutic community programs, have found them to be effective. Nevertheless, many inmates never have the opportunity to participate. In 2004, only 15 percent of drug-dependent inmates received treatment, while another 35 percent participated in less intensive self-help, peer counseling, or education programs ([@b40-ascp-05-1-4]).

Each year, more than 600,000 people leave prison and re-enter the Nation's communities. Within 3 years of their release, more than two-thirds of these individuals are rearrested, and one-fourth return to prison with a new sentence ([@b40-ascp-05-1-4]). Resumption of drug abuse precipitates or contributes to much of this recidivism. In addition to high relapse rates among parolees who never received treatment in prison, studies have found that more than 50 percent of graduates of many prison treatment programs relapse within 12 months (e.g., [@b37-ascp-05-1-4]). This statistic improves by 10 to 20 percent, however, when such graduates attend further treatment in the community ([@b26-ascp-05-1-4];[@b37-ascp-05-1-4];[@b52-ascp-05-1-4]).

Drug abusers who are on parole or probation require interventions that conform to principles of effective correctional treatment. The reasons are twofold. First, the patterns of thinking and behavior and life challenges that correctional treatment addresses to prevent recidivism also condition these patients' potential response to drug abuse treatment. Second, criminal activity that leads to a return to prison will interrupt and perhaps cancel the patient's progress toward recovery.
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This article summarizes principles of correctional treatment and reviews evidence-based drug abuse interventions for adult parolees and probationers. It then focuses on interventions that promote recovery in general drug-abusing populations and appear promising for use with criminal justice-involved patients. The current understanding of these issues benefits from systematic reviews and multiple-study meta-analyses that, over the past two decades, have identified key features contributing to the effectiveness of some interventions and provided quantitative estimates of effect sizes ([Table 1](#t1-ascp-05-1-4){ref-type="table"}).

PRINCIPLES OF EFFECTIVE CORRECTIONAL TREATMENT
==============================================

Dr. Donald Andrews and colleagues have been developing a body of research aimed at generating principles of effective correctional treatment---that is, treatment that can reduce rearrests and reincarcerations and can help offenders reintegrate into society ([@b1-ascp-05-1-4]; [@b2-ascp-05-1-4]). Andrews and colleagues argue that correctional programs that follow three principles related to *risk, criminogenic needs,* and *responsivity* produce the best outcomes. Numerous studies and meta-analyses support the importance of these principles ([@b2-ascp-05-1-4]; [@b26-ascp-05-1-4]; [@b33-ascp-05-1-4]). Developed for correctional populations, the principles apply to the large portion of the drug-abusing population that is involved in the criminal justice system.

The *risk principle* consists of two elements: (i) clients who are assessed as being at higher risk for reoffending are more likely to benefit from treatment than lower risk clients; and (ii) higher risk clients should receive more intensive services than lower risk clients. In the work of Andrews and colleagues, "risk" refers to the likelihood of future criminal behavior, but it is reasonable to assume that the principle also holds for drug abuse---that is, offenders with more severe drug problems should receive higher intensity treatment, while those at lower risk of relapse should be referred to less intensive programs, such as drug education, monitoring through drug testing, or self-help. Apart from ensuring optimal outcomes, matching problem severity to treatment approach makes for efficient use of scarce treatment resources. What constitutes high and low risk depends on whether the patient is a probationer or parolee and what treatment resources are available. The guidelines for designating clients as at high risk will be tighter in systems where intensive services are in short supply than in systems where they are more available.

According to the *criminogenic needs principle,* offenders have many needs, and correctional treatment should focus on those related to recidivism. [@b2-ascp-05-1-4] have identified the following targets as the most promising for correctional treatment: procriminal attitudes, procriminal associates, impulsivity, risk taking, limited self-control, poor problem-solving skills, poor educational and employment skills, and drug and alcohol dependence. These problems are all associated with drug abuse as well as recidivism. Offenders also have other needs that may require attention for various reasons, but are not associated with criminal behavior and have little or no impact on recidivism. These include enhancing self-esteem, improving living conditions, and addressing vaguely defined personal or emotional problems. Although correctional treatment should not focus on these needs, addiction treatment might benefit from such focus. Determining risk levels and needs requires assessment instruments suitable for identifying crime factors and drug use factors.

[@b2-ascp-05-1-4] describe the *responsivity principle* as concerned with "the selection of styles and modes of service that are (a) capable of influencing the specific types of intermediate targets that are set with offenders and (b) appropriately matched to the learning styles of offenders." This principle speaks both to the types of treatment that are most appropriate for offenders and to the characteristics of staff who deliver the treatment. The [@b2-ascp-05-1-4] argues that the approaches most appropriate to the learning styles of offenders include behavioral and social learning techniques such as "modeling, graduated practice, role playing, reinforcement, resource provision, and detailed verbal guidance and explanations (making suggestions, giving reasons, cognitive restructuring)." As for treatment staff, the responsivity principle recommends that they relate to their clients with warmth, flexibility, and enthusiasm, but with clear messages about the unacceptability of procriminal attitudes, behaviors, and associations.

Andrews and colleagues developed the risk/needs/responsivity principles from research on treatments for the general population of criminal offenders. In more recent work, the responsivity principle has been extended to apply to the distinctive needs of women, racial/ethnic groups, and clients of different ages ([@b24-ascp-05-1-4]). With specific reference to drug-abusing offenders, NIDA recently published research-based principles of treatment for this population ([@b43-ascp-05-1-4]; see *NIDA's Principles of Drug Abuse Treatment for Criminal Justice Populations*). The NIDA principles are consistent with the Andrews principles; together, they provide a framework for establishing programs and other interventions that have a high likelihood of reducing drug abuse and its consequences, including associated crime and further involvement in the criminal justice system.

RE-ENTRY INTERVENTIONS FOR DRUG-ABUSING PAROLEES
================================================

Multiple meta-analytical studies indicate that cognitive-behavioral therapy (CBT) and relapse prevention interventions reduce parolees' risks for recidivism ([Table 1](#t1-ascp-05-1-4){ref-type="table"}). One meta-analysis found that drug treatment as variously delivered by community providers significantly lowers recidivism among drug-abusing offenders. In addition, individual studies have suggested that pharmacological treatments for heroin abuse and gender-specific programs for women can both reduce drug abuse and crime, and improve psychological functioning in offender populations.

Two considerations strongly support a supposition that CBT and relapse prevention achieve their beneficial effects on recidivism partly by lowering the risk of drug relapse. First, relapse contributes to a high percentage of recidivism; second, other meta-analyses have demonstrated that CBT and relapse prevention curtail drug use among general community samples of drug abusers, significant portions of which typically consist of clients under criminal justice supervision. For these same reasons, case management and contingency management approaches, which also reduce drug use in general community samples, probably can reduce recidivism as well. The fact that a meta-analytical review of studies of case management for drug-abusing offenders did not demonstrate a significant impact on recidivism suggests that programs may need to adapt this approach to make it effective for this population.

Cognitive-Behavioral Therapy
----------------------------

CBT programs for offenders are designed to change the distorted thinking processes and patterns (often called "criminal thinking") that foster criminal behavior. As part of that agenda, CBT programs often incorporate relapse prevention techniques, which help drug-involved offenders to identify high-risk situations for drug use and crime, to develop and practice coping skills to deal with these situations, to create or strengthen social support systems, and to promote feelings of self-efficacy ([@b14-ascp-05-1-4]). Although community drug abuse treatment programs commonly administer CBT to promote recovery, only those that specialize in treating offenders are likely also to address criminogenic needs or criminal thinking. Without such attention, treatment may be insufficient, because those problems also contribute to drug relapse and reversion to criminal behavior.

A number of meta-analyses have found CBT programs to be effective in reducing recidivism and, less often, relapse to drug use among offenders (e.g., [@b27-ascp-05-1-4]; [@b45-ascp-05-1-4]; see [Table 1](#t1-ascp-05-1-4){ref-type="table"}). As the curriculum of CBT programs tends to be of relatively low intensity (usually one or two sessions a week for fewer than 20weeks; [@b27-ascp-05-1-4]), such programs may not be appropriate for those at highest risk for recidivism and relapse.

Several manualized "brand name" CBT programs are available for adult offenders, including the Cognitive Interventions Program ([@b42-ascp-05-1-4]), Moral Reconation Therapy *([www.moralreconation-therapy.com](www.moralreconation-therapy.com))*, Reasoning and Rehabilitation ([@b49-ascp-05-1-4]), and Thinking for a Change *(nicic.org/Library/016672)*. These programs are designed for use in criminal justice settings, but there is no reason that they cannot also be delivered, with proper training of staff, in community facilities that serve drug-abusing offenders.

Case Management
---------------

Parolees enter the community with multiple needs that must be addressed to increase their chances of success. In addition to substance abuse disorders, parolees may need assistance with housing, education, employment, transportation, family issues, medical and mental health problems, and documentation (e.g., Social Security card, driver's license). Parole officers can provide some assistance through referrals or service vouchers, but their case loads are large and their primary duty is supervision. Case managers identify and prioritize clients' needs, coordinate clients' drug treatment with services from other agencies, and follow up on client progress, subject to release-of-information agreements. Case management for drug-abusing offenders can be provided within probation or parole agencies, in treatment programs, or through an independent agency such as Treatment Accountability for Safer Communities (TASC).

Established in the early 1970s, TASC is the most prominent case management service for criminal justice-involved individuals. Under TASC, drug-abusing offenders (originally probationers, but more recently parolees as well) are offered the opportunity to enter community-based treatment. TASC identifies clients in need of drug treatment, assesses their individual needs, and refers them to community treatment as an alternative or as a supplement to criminal justice sanctions. Once clients are in treatment, TASC case managers monitor client progress and compliance with conditions of release. Case managers also assist clients in making appointments, intervene with service agencies to address problems, and follow up on client progress with treatment providers. TASC programs throughout the United States are guided by 13 critical elements, which provide structure and consistency to services for their clients *([www.nationaltasc.org/components-of-ntasc-programs/critical-elements](www.nationaltasc.org/components-of-ntasc-programs/critical-elements))*.

A rigorous evaluation of five TASC programs conducted in the early 1990s reported mixed, but overall favorable, outcomes for reducing drug use and crime ([@b3-ascp-05-1-4]). The failure to find consistently positive outcomes across the five programs suggests that treatment effects depend at least partly on the design and quality of specific TASC programs--- an observation that applies to any treatment model. Other case management models for drug abusers generally are effective in linking clients with needed services but appear to have limited effect on post-treatment drug use and other psychosocial outcomes ([@b22-ascp-05-1-4]).

Contingency Management
----------------------

An extensive body of laboratory and field research supports the effectiveness of contingency management, or the use of positive reinforcement, to promote abstinence and other desirable behaviors among clients in drug abuse treatment ([@b23-ascp-05-1-4]). Two meta-analyses of studies with general (i.e., not specifically parolee) drug-abusing samples ([@b34-ascp-05-1-4]; [@b48-ascp-05-1-4]; see [Table 1](#t1-ascp-05-1-4){ref-type="table"}) found that clients who received contingency management obtained 20 to 30 percent better drug use outcomes than did comparison clients who were given standard treatment. In general, the positive effects of contingency management tend to diminish in the months after treatment.

Within criminal justice settings, it may be assumed--- albeit on theoretical rather than empirical grounds--- that contingency management may be particularly useful with offenders who enter treatment under legal pressure. Reinforcement for abstinence or other treatment- related behavior is potentially more effective with this population than coercion and the threat of punishment, which do not necessarily motivate clients to engage in treatment and may provoke active resistance. Although contingency management is a promising approach for drug-abusing parolees, research is needed to examine how best to use it, given that the criminal justice setting traditionally tends to rely on sticks rather than carrots to change behavior.

Residential Treatment
---------------------

Residential treatment in the community usually follows the therapeutic community (TC)model ([@b13-ascp-05-1-4]). TCs are highly structured residential programs in which clients participate for 6 to 12months. TCs focus on resocializing the client to a drug-free, crime-free lifestyle, with the "community" of staff and residents and their interactions supplying the primary therapeutic input. Many TCs also provide a variety of support services to facilitate resocialization.

The TC is the most intensive and expensive treatment for those with drug dependence. Per the risk principle, it should be reserved for offenders who are at high risk and those who have severe drug dependence. As noted earlier, the criteria for identifying offenders as at high risk and their drug problems as of high severity depend on the nature of the offender population within a given system and the relative availability of TC treatment and other forms of less expensive treatment. In many jurisdictions, TC treatment is one of the community treatment options for parolees who have participated in prison-based TCs and ensures a continuum of care from one criminal justice setting to another.

TCs have a long history of treating clients involved in the criminal justice system, and the TC focus on treating the whole person (as opposed to drug problems exclusively) is particularly appropriate for this population. A considerable body of research supports the effectiveness of TC treatment for offenders, particularly in a continuum of care that involves prison treatment followed by community treatment ([@b26-ascp-05-1-4]; [@b37-ascp-05-1-4]; [@b47-ascp-05-1-4];[@b52-ascp-05-1-4]). As has been noted, a key finding of most of these studies is that offenders who participate in prison-based TC programs generally have outcomes similar to those who do not receive treatment, unless they also attend some type of community treatment.

Pharmacotherapy
---------------

A number of medications have been found to be effective in treating opiate addiction, including methadone, buprenorphine, and naltrexone ([@b7-ascp-05-1-4]). The handful of research studies that have evaluated the use of medication with opiate-dependent offenders has documented positive outcomes with the use of naltrexone with Federal probationers (i.e., parolees; [@b10-ascp-05-1-4]) and with the use of methadone in jail ([@b35-ascp-05-1-4]) and in prison ([@b25-ascp-05-1-4]). The main barrier to greater use of pharmacotherapy with opiate-dependent offenders is not the small research base, but rather resistance by many criminal justice agencies and treatment providers.

Programs for Women
------------------

Clinicians and researchers have recognized for some time that drug-abusing women have needs that are distinct from those of men. They are more likely to have co-existing psychiatric disorders, lower self-esteem, more severe drug abuse histories, and extensive histories of sexual and physical abuse ([@b20-ascp-05-1-4]; [@b28-ascp-05-1-4]). Drug-abusing women offenders also are at high risk of acquiring sexually transmitted diseases, including infection with HIV, because of their participation in prostitution for money or drugs ([@b38-ascp-05-1-4]).

### NIDA'S PRINCIPLES OF DRUG ABUSE TREATMENT FOR CRIMINAL JUSTICE POPULATIONS (2006)

1.  Drug addiction is a brain disease that affects behavior.

2.  Recovery from drug addiction requires effective treatment, followed by management of the problem over time.

3.  Treatment must last long enough to produce stable behavioral change.

4.  Assessment is the first step in treatment.

5.  Tailoring services to fit the needs of the individual is an important part of effective drug abuse treatment for criminal justice populations.

6.  Drug use during treatment should be carefully monitored.

7.  Treatment should target factors that are associated with criminal behavior.

8.  Criminal justice supervision should incorporate treatment planning for drug-abusing offenders, and treatment providers should be aware of correctional supervision requirements.

9.  Continuity of care is essential for drug abusers re-entering the community.

10. A balance of rewards and sanctions encourages prosocial behavior and treatment participation.

11. Offenders with co-occurring drug abuse and mental health problems often require an integrated treatment approach.

12. Medications are an important part of treatment for many drug-abusing offenders.

13. Treatment planning for drug-abusing offenders who are living in or reentering the community should include strategies to prevent and treat serious, chronic medical conditions, such as HIV/AIDS, hepatitis B and C, and tuberculosis.

Compared with programs for men or those that treat both men and women, treatment programs that are designed to be responsive to the needs of women feature different philosophies, treatment approaches, types of services, and staffing patterns. Such programs place a greater emphasis on social model, peer-based treatment approaches than do more general programs ([@b20-ascp-05-1-4]). In response to broader societal gender differences, such as women's lower economic status and primary responsibility for child-rearing, these programs are more likely to dispense a wider array of services, including services for children. Because of the high prevalence of past and current sexual and physical abuse among women offenders, re-entry programs increasingly include trauma-informed elements within their curricula ([@b11-ascp-05-1-4]; [@b41-ascp-05-1-4]). A number of studies indicate that women drug abusers do better in treatment programs that are tailored to their particular needs, rather than generic in approach (for a meta-analysis of women's treatment programs, see [@b44-ascp-05-1-4]).
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Continuing Care
---------------

Regardless of the choice of intervention, positive outcomes from prison-based drug treatment programs are most likely to persist when offenders participate in post-release community treatment. The success of a continuing care model, which involves prison treatment followed by community treatment, is contingent on the parolee's appearing for admission to the community treatment program and continuing to attend. Many parolees do not do so, even in States where treatment is a condition of release for parolees with identified drug problems.

Clear guidance from research as to how to increase parolee enrollment in treatment is lacking, but criminal justice agencies and treatment programs can try a variety of potentially effective techniques. They may, for example, use the same provider in prison and in the community, give incentives for enrollment in community treatment, utilize case management to coordinate services, provide transportation from prison to the program, or enlist the parole officer and family members to apply pressure and encouragement to enter treatment.

Three months is generally considered to be the minimum period that a drug abuser must stay in formal treatment to achieve favorable outcomes. Some individuals may need more time, depending on the severity of their drug problems, the presence of other needs, and the intensity of the treatment ([@b50-ascp-05-1-4]). Dropout prior to 3months is common, however (e.g., [@b5-ascp-05-1-4]). Surprisingly, some evidence suggests that drug-abusing parolees who leave community treatment after a few weeks have poorer outcomes than those who do not attend community treatment at all ([@b53-ascp-05-1-4]). Treatment programs that serve offenders can use a number of evidence-based techniques to promote participation in treatment, including motivational interviewing ([@b39-ascp-05-1-4]), cognitive enhancement interventions ([@b12-ascp-05-1-4]), and contingency management ([@b23-ascp-05-1-4]). Client engagement in treatment, as well as maintenance of recovery, is also enhanced by participation in formal and informal social support networks, including Twelve-Step and other self-help groups.

CLINICAL ISSUES IN PROVIDING TREATMENT TO PAROLEES
==================================================

Several issues are important to the effective provision of evidence-based practices to parolees. Positive outcomes are less likely without proper assessment and well-implemented interventions. Clinicians must help mandated clients make the transition from legal compliance with parole conditions to willing participation in treatment.

Assessment
----------

It is essential that treatment providers screen and assess prospective clients with appropriate validated instruments. The initial screening and assessment results can help clinicians determine whether a client needs treatment (as opposed to education or self-help), which level of treatment intensity is appropriate, and which needs should be addressed and with what priority. After a client has participated in treatment for several months, reassessment may inform a decision to raise or lower the level of care or to address emerging needs.

Screening and assessment instruments that have been validated and that take into account criminal history and risk for recidivism are available for use with drug-abusing offenders, many of them at no cost (see [@b8-ascp-05-1-4], Chapter 2 and Appendix C; *download.ncadi.samhsa.gov/Prevline/pdfs/bkd526.pdf )*. Program staff members will require training in proper administration, scoring, and interpretation. Online information about assessment instruments for drug-abusing offenders is available at *[www.ibr.tcu.edu/pubs/datacoll/datacoll.html,lib.adai.washington.edu/instruments/](www.ibr.tcu.edu/pubs/datacoll/datacoll.html,lib.adai.washington.edu/instruments/),* and *[www.nicic.org/Library/011716](www.nicic.org/Library/011716).*

Implementation
--------------

All the interventions discussed in this article can be considered "evidence-based," as each has produced positive outcomes in multiple studies with rigorous research designs. Nevertheless, not all community programs that adopt evidence-based practices have similar success with their clients. Much depends on how practices are implemented. Successful implementation requires qualified staff, solid plans for training and staff development, fidelity to the main features of the model, and organizational characteristics that promote the successful adoption of new practices ([@b17-ascp-05-1-4]; [@b18-ascp-05-1-4]). As treatment for drug-abusing parolees usually involves personnel from both criminal justice and treatment agencies, forging collaborative and cooperative relationships is also critical ([@b51-ascp-05-1-4]).

Mandated Treatment
------------------

Many drug-abusing parolees are mandated to treatment or at least are under pressure from their parole officers to enter treatment after a relapse. Such clients do as well as or even better than clients who enter voluntarily ([@b16-ascp-05-1-4]), probably because they remain in treatment longer than voluntary clients. Still, as [@b29-ascp-05-1-4] note, "A stable recovery cannot be maintained by external (legal) pressures only; motivation and commitment must come from internal pressure." Legal pressure may compel offenders to comply with treatment requirements and place them in a situation where the tools and supports for change are available. Progress only occurs, however, when external pressure is transformed into an internal desire for change and a willingness to take steps toward it.

Although the motivation of drug-abusing parolees to engage in treatment may be low initially, motivation can increase as a result of peer pressure, clinical techniques, and insight developed over the course of treatment. Because motivation is a dynamic process, programs can actively intervene to shift the balance in favor of change. Whatever level of initial motivation clients bring to treatment, clinicians may use a variety of tools, many discussed earlier, to promote treatment engagement with a consequent increase in the chance of positive outcomes.

CONCLUSION
==========

A variety of effective approaches are available for the treatment of drug-abusing parolees. Whether they, in fact, produce expected reductions in drug use and crime and improvements in psychosocial functioning depends on the ability of criminal justice agencies and public health agencies and programs to develop collaborative systems of care that integrate the supervision and monitoring functions of criminal justice with the treatment and service delivery functions of public health ([@b36-ascp-05-1-4];[@b51-ascp-05-1-4]). Ideally, a treatment system for drug-abusing offenders would extend horizontally and vertically. Horizontally, it would link criminal justice agencies with treatment agencies and other community resources to provide referrals and services for this population. Vertically, the system would incorporate a wide range of alternative strategies answering to the needs, characteristics, and life status of its clients, including extended care throughout the required period of time. Re-entry programs that follow the principles of effective treatment of offenders, use tested treatment approaches and techniques, and maintain collaborative relationships with criminal justice agencies and social service systems provide the best opportunity for parolees to reduce their drug use and crime and to successfully reintegrate into society.
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###### 

Effect Sizes From Meta-Analyses of Treatment Interventions for Drug-Abusing and Offender Populations

  INTERVENTION                                  CITATION                                                         SETTING                    OUTCOME                 NO. OF STUDIES (NO. OF SUBJECTS)   EFFECT SIZE *(r)*   SIGNIFICANCE
  --------------------------------------------- ---------------------------------------------------------------- -------------------------- ----------------------- ---------------------------------- ------------------- --------------
  **General Drug Abuser Treatment Samples**                                                                                                                                                                                
  Case management                               [@b22-ascp-05-1-4]                                               Community                  Drug use                8 (2,391)                          .06                 NS
  Case management                               [@b22-ascp-05-1-4]                                               Community                  Linkage with services   11 (3,132)                         .21                 S
  Cognitive-behavioral therapy                  [@b15-ascp-05-1-4]                                               Community                  Drug use                13 (NR)                            .14                 S
  Community drug treatment                      [@b46-ascp-05-1-4]                                               Community                  Drug use                78 (NR)                            .15                 S
  Contingency management                        [@b15-ascp-05-1-4]                                               Community                  Drug use                14 (NR)                            .28                 S
  Contingency management                        [@b21-ascp-05-1-4]                                               Community (Methadone tx)   Drug use                30 (NR)                            .25                 S
  Contingency management                        [@b34-ascp-05-1-4]                                               Community                  Drug use                30 (2,390)                         .32                 S
  Contingency management                        [@b48-ascp-05-1-4]                                               Community                  Drug use                47 (NR)                            .21                 S
  Motivational interviewing                     [@b6-ascp-05-1-4]                                                Community                  Drug use                5 (717)                            .27                 S
  Relapse prevention                            [@b15-ascp-05-1-4]                                               Community                  Drug use                5 (NR)                             .16                 S
  **General Offender Treatment Samples**                                                                                                                                                                                   
  Behavioral reinforcement/incentives           [@b45-ascp-05-1-4][\*](#tfn3-ascp-05-1-4){ref-type="table-fn"}   Institution/community      Recidivism              23 (1,935)                         .07                 NS
  Cognitive-behavioral therapy                  [@b27-ascp-05-1-4][\*](#tfn3-ascp-05-1-4){ref-type="table-fn"}   Institution/community      Recidivism              58 (NR)                            .11                 S
  Cognitive-behavioral therapy                  [@b30-ascp-05-1-4][\*](#tfn3-ascp-05-1-4){ref-type="table-fn"}   Institution/community      Arrest                  9 (NR)                             .14                 S
  Cognitive-behavioral therapy                  [@b4-ascp-05-1-4]                                                Institution/community      Recidivism              25 (6,546)                         .07                 S
  Cognitive-behavioral therapy                  [@b45-ascp-05-1-4][\*](#tfn3-ascp-05-1-4){ref-type="table-fn"}   Institution/community      Recidivism              44 (8,345)                         .14                 S
  Relapse prevention                            [@b14-ascp-05-1-4]                                               Institution/community      Reconviction            31 (NR)                            .13                 NR
  **Drug-Abusing Offender Treatment Samples**                                                                                                                                                                              
  Case management                               [@b4-ascp-05-1-4]                                                Community                  Recidivism              12 (2,572)                         .03                 NS
  Cognitive-behavioral therapy                  [@b32-ascp-05-1-4][\*](#tfn3-ascp-05-1-4){ref-type="table-fn"}   Institution/community      Substance use           10 (1,633)                         .08                 S
  Community drug treatment                      [@b4-ascp-05-1-4]                                                Community                  Recidivism              5 (54,334 )                        .07                 S

The table includes meta-analyses published in 2000 or later. All of the effect sizes are positive, indicating that the treatment group had a better outcome than the comparison group. Effect sizes from studies that use the standardized mean difference (*d*) have been converted to the correlation coefficient (*r*; [@b31-ascp-05-1-4]). Conventionally, an effect size of *r* = .10 is small; *r* = .30 is medium; and *r* = .50 is large ([@b9-ascp-05-1-4]). Another way to interpret *r* is as the percentage difference in the outcome between the treatment group and the comparison group; thus, an effect size of *r* = .15 for arrests can be interpreted as a 15 percentage point difference in arrests in favor of the treatment group.

S, significant; NS, not significant; NR, not reported.

These studies include both juvenile and adult offenders.
